title: Melanoma BRAF fusions--response.
authors.affiliation: Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
authors.forename: Katherine E
authors.initials: KE
authors.lastname: Hutchinson
authors.affiliation: Foundation Medicine, Inc., Cambridge, Massachusetts. Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York.
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Ross
authors.affiliation: Foundation Medicine, Inc., Cambridge, Massachusetts.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Stephens
authors.affiliation: Foundation Medicine, Inc., Cambridge, Massachusetts.
authors.forename: Vincent A
authors.initials: VA
authors.lastname: Miller
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Sosman
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. william.pao@vanderbilt.edu.
authors.forename: William
authors.initials: W
authors.lastname: Pao
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D048493:Proto-Oncogene Proteins B-raf